pubmed-article:10066991 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10066991 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
pubmed-article:10066991 | lifeskim:mentions | umls-concept:C0871396 | lld:lifeskim |
pubmed-article:10066991 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10066991 | pubmed:dateCreated | 1999-3-23 | lld:pubmed |
pubmed-article:10066991 | pubmed:abstractText | The role of transient and sustained channels in masking was investigated in groups with positive and negative symptoms in schizophrenia and in a control group. The target stimulus was a 3.0 c/deg sinusoidal grating, which was masked at 11 stimulus-onset asynchronies between -40 to 360 ms by a 1.0 c/deg mask or an 11.0 c/deg mask. The results showed that there was no difference between the control and positive-symptom groups in the perception of the 3 c/deg target stimulus, nor was there a difference when the target was masked by 1 or 11 c/deg masking stimuli. In comparison with the control and positive-symptom groups, the negative-symptom group showed a significantly higher threshold for the perception of the 3 c/deg target stimulus and more masking with a 1 c/deg mask, but not with an 11 c/deg mask. The results provide evidence for distinguishable differences in visual masking between groups with positive and negative symptoms in schizophrenia. | lld:pubmed |
pubmed-article:10066991 | pubmed:language | eng | lld:pubmed |
pubmed-article:10066991 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10066991 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10066991 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10066991 | pubmed:month | Feb | lld:pubmed |
pubmed-article:10066991 | pubmed:issn | 0021-843X | lld:pubmed |
pubmed-article:10066991 | pubmed:author | pubmed-author:CurranC ECE | lld:pubmed |
pubmed-article:10066991 | pubmed:author | pubmed-author:SlaghuisW LWL | lld:pubmed |
pubmed-article:10066991 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10066991 | pubmed:volume | 108 | lld:pubmed |
pubmed-article:10066991 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10066991 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10066991 | pubmed:pagination | 42-50 | lld:pubmed |
pubmed-article:10066991 | pubmed:dateRevised | 2009-11-11 | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:meshHeading | pubmed-meshheading:10066991... | lld:pubmed |
pubmed-article:10066991 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10066991 | pubmed:articleTitle | Spatial frequency masking in positive- and negative-symptom schizophrenia. | lld:pubmed |
pubmed-article:10066991 | pubmed:affiliation | Department of Psychology, University of Tasmania, Hobart, Australia. walter.slaghuis@utas.edu.au | lld:pubmed |
pubmed-article:10066991 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10066991 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10066991 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
pubmed-article:10066991 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10066991 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10066991 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10066991 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10066991 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10066991 | lld:pubmed |